Felix Health vs Maple (2026): Which GLP-1 Telehealth Is Better for Canadians?

At a Glance

What Is Maple?

Maple is a Canadian telehealth platform founded in 2015 that connects patients with licensed physicians and nurse practitioners for a wide range of medical concerns - from urgent care and mental health to chronic condition management and prescription renewals. It is one of Canada's largest and best-funded telehealth companies, with coverage across all provinces.

Maple offers GLP-1 prescriptions as one category within its general clinical offering. Patients can consult with a Maple physician about weight management, and if clinically appropriate, receive a prescription for Ozempic, Wegovy, Mounjaro, or generic semaglutide. The clinical quality is high - Maple's physicians are licensed and follow standard Canadian prescribing guidelines.

The distinction is that Maple is not a GLP-1 specialist platform. Its protocols, follow-up systems, and pricing structure are designed for general telehealth use - not specifically for the multi-year titration and ongoing clinical management that GLP-1 therapy typically requires.

Specialist vs Generalist

Felix Health was built specifically for GLP-1 weight management. Its clinical protocols, intake questionnaires, follow-up schedules, and patient communications are all designed around the specific requirements of semaglutide and tirzepatide therapy. The platform handles lab ordering, titration tracking, side effect monitoring, and dose adjustments as core features - not as add-on services.

Maple's strength is breadth. A patient who woke up with an ear infection, wants a prescription renewal for blood pressure medication, and is also considering GLP-1 therapy can manage all three on Maple in a single account. That versatility is genuinely valuable for patients with multiple healthcare needs.

For GLP-1 specifically, however, the specialist advantage matters. GLP-1 medications involve a 4-20 week titration schedule, regular dose adjustments, potential side effect management, and periodic reassessment of cardiovascular, metabolic, and other clinical markers. A platform built around these specific requirements handles them more efficiently than a generalist platform trying to accommodate them within a general consultancy framework.

Pricing: Bundled vs Per-Consult

This is where the two platforms diverge most significantly for long-term GLP-1 patients.

Felix Health charges $99 once for the initial consultation and approximately $149 per month for the ongoing program - which includes the medication cost, clinical support, and all follow-up consultations for dose adjustments and check-ins. There are no additional per-visit fees once you are enrolled.

Maple charges $69-99 per consultation - which includes the initial GLP-1 assessment and each subsequent visit. For a new GLP-1 patient moving through a standard titration schedule, the number of consultations required in the first year can be significant: initial assessment, labs review, 0.25 mg start, 0.5 mg adjustment, 1 mg adjustment, any side-effect check-ins, and periodic renewals. At $69-99 per visit, those consultations add up quickly.

The cost differential is most pronounced in the first 6-12 months of GLP-1 therapy, when titration is active and clinical touchpoints are most frequent. In year two and beyond, at a stable maintenance dose, the per-visit cost gap narrows - but Felix still typically comes out ahead given its included follow-up model.

Speed and Availability

Maple's 24/7 on-demand doctor access is a genuine differentiator for acute care. For a sudden illness or same-day prescription need, Maple's ability to connect patients with a physician within minutes is unmatched in Canadian telehealth.

For GLP-1 prescriptions specifically, on-demand access matters less. GLP-1 therapy requires an asynchronous clinical assessment - review of health history, metabolic markers, contraindications, and a BMI-based eligibility check. This process benefits from thoughtful review rather than a fast real-time consultation. Both Felix and Maple use an asynchronous review model for GLP-1 intake. Felix targets a 24-hour review turnaround; Maple's asynchronous service typically delivers within a similar window.

From intake to medication in hand, both platforms typically take 5-7 business days for new patients, assuming labs are either on file or can be completed quickly. Maple's real-time availability provides no advantage at this specific step because the clinical assessment itself requires async review.

Province Coverage

Maple operates in all Canadian provinces, including Quebec. Felix Health operates in 9 provinces, excluding Quebec and New Brunswick. For patients in those provinces, Maple is the only option between the two platforms.

For all other provinces, both platforms are available and the province is not a deciding factor. The choice reverts to the clinical model and cost comparison described above.

Ongoing Titration Management

Titration - the gradual increase of GLP-1 dose over several months - is where the Felix versus Maple comparison becomes most consequential for most patients.

Standard semaglutide titration for weight management starts at 0.25 mg weekly and progresses in increments to 0.5 mg, 1 mg, 1.7 mg, and ultimately 2.4 mg (Wegovy). Mounjaro starts at 2.5 mg and titrates up to 15 mg through five increments. Each dose increase typically requires clinical review and prescription update. Over 20 weeks of titration, that can mean 4-6 clinical touchpoints just to reach a maintenance dose.

Felix Health bundles all of these touchpoints into its program. You do not pay a separate fee each time your dose is adjusted. Your physician is available for dose titration management as part of the $149/month program.

Maple charges a consultation fee for each clinical encounter, including dose adjustments. A patient titrating through a full semaglutide protocol on Maple will pay 4-6 additional consultation fees of $69-99 each over the first several months. That adds $280-600 to the cost of reaching maintenance dose - a cost that does not exist on the Felix platform.

For patients who reach their maintenance dose quickly and rarely need clinical contact thereafter, the gap narrows. For patients who titrate slowly, experience side effects requiring multiple consultations, or need frequent prescription adjustments, Felix's bundled model produces substantially lower total cost.

Pros and Cons

Verdict

For ongoing GLP-1 weight management, Felix Health wins on cost and clinical specialization. The bundled pricing model eliminates per-visit fees for the titration visits, dose adjustments, and check-ins that GLP-1 therapy requires. Over 12 months, Felix patients typically spend $300-600 less than equivalent Maple patients, while receiving a more purpose-built clinical experience.

Maple wins on province coverage and on-demand access. If you live in Quebec, you cannot use Felix, and Maple is the better option. If you need same-day physician access for an acute issue and already use Maple for multiple health needs, the convenience of a single platform may justify the per-consult cost differential.

For the majority of Canadians starting a GLP-1 weight loss program for the first time, in a province where both platforms operate, Felix Health is the more cost-effective and clinically appropriate choice. The specialist model and bundled pricing are clear advantages for a treatment category that requires regular clinical management over an extended period.